-+ 0.00%
-+ 0.00%
-+ 0.00%

SCHOLAR ROCK RESUBMITS APITEGROMAB MARKETING AUTHORISATION APPLICATION (MAA) TO EUROPEAN MEDICINES AGENCY (EMA) FOR TREATMENT OF CHILDREN AND ADULTS WITH SPINAL MUSCULAR ATROPHY (SMA)

Reuters·10/08/2026 12:00:03

Please log in to view news